U.S. Healthcare Policy Priorities: Telehealth, Surprise Billing, Drug Pricing, Medicaid, Value-Based Care & Equity

U.S. healthcare policy sits at a crossroads as policymakers, providers, and patients wrestle with rising costs, inconsistent access, and rapid technological change. Several policy priorities are shaping the near-term landscape: telehealth regulation, surprise billing protections, drug pricing pressure, and efforts to center equity in coverage and care delivery.

Telehealth: sustaining gains while tightening standards
Telehealth adoption surged when regulatory and payment barriers were relaxed. Today the debate focuses on how to make virtual care both sustainable and safe. Key policy levers include payment parity for telehealth visits, cross-state licensure compacts for clinicians, and standards for remote monitoring and digital therapeutics. Payers and providers are experimenting with hybrid care models that blend virtual check-ins with in-person visits to improve chronic disease management and reduce avoidable ER use. Effective policy balances access—especially for rural and mobility-limited patients—with quality, privacy, and fraud prevention.

Surprise billing and patient financial protection
Protections against surprise medical bills have reduced unexpected financial shocks for many patients, but operational challenges remain. Clearer billing guidance, robust dispute resolution processes, and transparent price-estimation tools can further limit balance billing. States and federal regulators are continuing to refine enforcement mechanisms and data reporting so consumers see accurate expected costs before receiving care.

Strengthening price transparency across the system helps patients make informed decisions and builds market accountability.

Prescription drug pricing: targeted reforms and market dynamics

Prescription drug affordability continues to dominate public concern. Policy options under discussion include targeted negotiation for certain high-cost drugs, increased use of value-based purchasing arrangements, and expanded generic and biosimilar competition.

Payers and manufacturers are also piloting outcomes-based contracts that tie payment to real-world effectiveness. Crucially, any pricing reform must preserve incentives for innovation while removing perverse incentives that push up list prices and patient cost-sharing.

Medicaid coverage, state variation, and access gaps
Medicaid remains the backbone for low-income individuals and many older adults with disabilities, but access varies widely by state. Coverage gaps persist in states that have not expanded eligibility, leaving millions without affordable options.

Policymakers can pursue incremental improvements—such as continuous eligibility, simplified enrollment, and targeted wraparound benefits—to reduce churn and improve preventive care uptake.

Strengthening community-based services and behavioral health integration within Medicaid programs can yield both better outcomes and lower total-cost-of-care over time.

Value-based care and payment reform
Shifting away from fee-for-service toward value-based payment models is an ongoing priority. Bundled payments, accountable care organizations, and shared-savings arrangements aim to align incentives around outcomes and efficiency. Early adopters show promise in reducing avoidable utilization and improving care coordination, but scaling requires better data sharing, standardized outcome measures, and risk adjustment mechanisms to protect providers serving higher-need populations.

Centering health equity
Policy choices increasingly emphasize equity—addressing social determinants, maternal health disparities, and chronic disease burdens in underserved communities. Investments in community health workers, strengthened behavioral health access, and targeted maternal care supports can close gaps that drive long-term costs and poor outcomes. Data collection and measurement must follow, enabling policymakers to track progress and direct resources where they matter most.

What stakeholders can do now
Policymakers should prioritize pragmatic, evidence-based interventions that expand access without sacrificing quality. Providers and health systems can accelerate value-based partnerships and build robust telehealth capabilities. Payers can enhance transparency and adopt payment models that reward outcomes. For patients, understanding coverage options, using price-estimate tools, and engaging in preventive care remain powerful ways to reduce risk and financial strain.

The policy agenda is complex, but coordinated action across federal and state levels—paired with stakeholder engagement—can make care more affordable, accessible, and equitable for Americans.